KIAA0101 expression levels in liver cancer, glioma, lung nonsmall-cell cancer, pancreatic cancer, breast cancer, esophageal cancer, colorectal cancer, and kidney cancer exhibited an insignificant difference based on both Affymetrix and RNA-seq profiling (Figure 1A and 1B). This evidence concerns the gene PCLAF and breast carcinoma.